Calumet, Inc. /DE shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.
“Proposal No. 3 - Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows: For: 70,973,872 Against: 194,987 Abstain: 212,786”
Shareholder Votes
Calumet, Inc. /DE shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-06-02 meeting.
“Proposal No. 2 - Advisory Vote to Approve Executive Compensation The Company’s stockholders approved, on a non-binding, advisory basis, the Company’s executive compensation. The voting results were as follows: For: 50,222,235 Against: 956,685 Abstain: 276,087 Broker Non-Votes: 19,926,638”
Shareholder Votes
Calumet, Inc. /DE shareholders approved Election of Class II Directors at the 2026-06-02 meeting.
“The Company’s stockholders elected the three Class II director nominees listed below as directors of the Company, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified. The voting results were as follows: Nominees For Withhold Broker Non-Votes Todd Borgmann 51,089,604 365,403 19,926,638 Daniel J. Sajkowski 50,332,470 1,122,537 19,926,638 Bradford T. Sanders 51,130,433 324,574 19,926,638”
Earnings Releases
Calumet, Inc. /DE reported the quarter ended March 31, 2026 results: net income $317.0 million net loss, EPS basic loss per common share of $3.64.
“Calumet Reports First Quarter 2026 Results · First Quarter 2026 net loss of $317.0 million, or basic loss per common share of $3.64”
Material Agreements
Calumet, Inc. /DE entered into 9.75% Senior Notes due 2031 with initial purchasers valued at $150,000,000 aggregate principal amount, issued at 105% of par, plus accrued interest; net proceeds (effective 2026-03-17).
“On March 17, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), each a subsidiary of Calumet, Inc. (the “Company”), issued $150.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Additional Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”).”
Debt Financings
Calumet, Inc. /DE incurred senior notes of $150.0 million aggregate principal amount with Wilmington Trust, National Association at 9.75% maturing February 15, 2031.
“On March 17, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), each a subsidiary of Calumet, Inc. (the “Company”), issued $150.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Additional Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”).”
Material Agreements
Calumet, Inc. /DE entered into Tenth Amendment to the Third Amended and Restated Credit Agreement with the lenders party thereto and Bank of America, N.A., as administrative agent (effective 2026-03-12).
“On March 12, 2026, the Company entered into the Tenth Amendment to the Third Amended and Restated Credit Agreement (the “Tenth Amendment”), which modifies the Third Amended and Restated Credit Agreement, dated as of February 23, 2018, by and among the General Partner, the Partnership, certain of the Company’s subsidiaries party thereto, the lenders party thereto and Bank of America, N.A., as administrative agent, to permit the issuance of, and the incurrence of indebtedness in connection with, the Additional Notes.”
Material Agreements
Calumet, Inc. /DE entered into Purchase Agreement with BofA Securities, Inc. as representative of the several initial purchasers valued at $150.0 million (effective 2026-03-12).
“On March 12, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”), Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), Calumet, Inc. (the “Company”), Calumet GP, LLC (the “General Partner”) and certain subsidiary guarantors named therein (the “Subsidiary Guarantors”) entered into a purchase agreement (the “Purchase Agreement”) with BofA Securities, Inc. as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), under which they agreed to sell $150.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Additional Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended.”
Debt Financings
Calumet, Inc. /DE amended credit facility of $500.0 million with Bank of America, N.A., as administrative agent maturing January 23, 2031.
“The Ninth Amendment modified the Credit Agreement to (i) extend the maturity date to January 23, 2031, (ii) provide for commitments of $500.0 million, subject to borrowing base limitations”
Material Agreements
Calumet, Inc. /DE amended Ninth Amendment to the Third Amended and Restated Credit Agreement with the lenders party thereto and Bank of America, N.A., as administrative agent valued at $500.0 million (effective 2026-01-23).
“On January 23, 2026, Calumet, Inc. (the “Company”) entered into the Ninth Amendment to the Third Amended and Restated Credit Agreement (the “Ninth Amendment”).”
Material Agreements
Calumet, Inc. /DE entered into Indenture with Wilmington Trust, National Association valued at $405.0 million (effective 2026-01-12).
“The Notes are governed by an Indenture, dated as of January 12, 2026 (the “Indenture”), entered into by the Issuers and certain guarantors named therein with Wilmington Trust, National Association, as trustee.”
Debt Financings
Calumet, Inc. /DE incurred senior notes of $405.0 million at 9.75% maturing February 15, 2031.
“On January 12, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), each a subsidiary of Calumet, Inc. (the “Company”), issued $405.0 million aggregate principal amount of a new series of the Issuers’ 9.75% Senior Notes due 2031 (the “Notes”) in a private placement”
Material Agreements
Calumet, Inc. /DE entered into Purchase Agreement with BofA Securities, Inc. as representative of the several initial purchasers named therein valued at $405.0 million aggregate principal amount (effective 2026-01-07).
“On January 7, 2026, Calumet, Inc. (the “Company”), Calumet Specialty Products Partners, L.P. (the “Partnership”), Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), Calumet GP, LLC (the “General Partner”) and certain subsidiary guarantors named therein (the “Subsidiary Guarantors”) entered into a purchase agreement (the “Purchase Agreement”) with BofA Securities, Inc. as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), under which they agreed to sell $405.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended.”
Debt Financings
Calumet, Inc. /DE incurred lease obligation of approximately $120 million with Stonebriar Commercial Finance LLC at approximately 10.75% per year maturing seven-year term.
“2”) with Stonebriar Commercial Finance LLC (“Stonebriar”). Property Schedule No. 2 supplements the Master Lease Agreement, dated as of February 12, 2021 (the “Master Lease” and, together with Property Schedule No.”
David A. Lunin changed role as Chief Financial Officer at Calumet, Inc. /DE.
“Beginning on the Effective Date, David A. Lunin will no longer serve as the Company’s principal accounting officer. Mr. Lunin will continue to serve as the Executive Vice President, Chief Financial Officer and principal financial officer of the Company.”
John R. Krutz was appointed as Chief Accounting Officer at Calumet, Inc. /DE.
“the Board of Directors of the Company (the “Board”) has appointed John R. Krutz to serve as the Company’s Chief Accounting Officer and principal accounting officer, effective May 21, 2025”
David Lunin changed role as Principal Accounting Officer at Calumet, Inc. /DE.
“On the Effective Date, David Lunin will assume the role as the Company’s principal accounting officer, which is in addition to Mr. Lunin’s existing roles as Executive Vice President, Chief Financial Officer and principal financial officer of the Company.”
Vincent Donargo resigned as Chief Accounting Officer at Calumet, Inc. /DE.
“On April 1, 2025, Vincent Donargo notified Calumet, Inc. (the “Company”) of his resignation as the Company’s Chief Accounting Officer and principal accounting officer, effective April 15, 2025 (the “Effective Date”).”
M&A Transactions
Calumet, Inc. /DE completed an acquisition involving Calumet GP, LLC for 5.5 million shares of Common Stock and 2.0 million Warrants (closed 2024-07-10).
“Merger Sub I merged with and into the General Partner, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of the Company, and all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5.5 million shares of Common Stock and 2.0 million Warrants (the “GP Merger”).”
M&A Transactions
Calumet, Inc. /DE completed an acquisition involving Calumet Specialty Products Partners, L.P. (closed 2024-07-10).
“Merger Sub II merged with and into the Partnership, with the Partnership continuing as the surviving entity and a wholly owned subsidiary of the Company, and all of the common units representing limited partner interests in the Partnership (“Common Units”) were exchanged into the right to receive an equal number of shares of Common Stock (the “Partnership Merger”);”
M&A Transactions
Calumet, Inc. /DE underwent a change of control involving Calumet Specialty Products Partners, L.P., Calumet GP, LLC, The Heritage Group (closed 2024-07-10).
“On July 10, 2024, the Company completed the previously announced transactions contemplated by the Conversion Agreement.”
Stephen P. Mawer was appointed as Chairperson of the Board at Calumet, Inc. /DE.
“Stephen P. Mawer previously served as the sole director of the Company and was appointed as the Chairperson of the Board upon completion of the Conversion.”
Todd Borgmann was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Karen A. Twitchell was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
John G. Boss was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Jennifer G. Straumins was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Paul C. Raymond III was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Daniel L. Sheets was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Amy M. Schumacher was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Daniel J. Sajkowski was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
James S. Carter was appointed as Director at Calumet, Inc. /DE.
“appointed James S. Carter, Daniel J. Sajkowski, Amy M. Schumacher, Daniel L. Sheets, Paul C. Raymond III, Jennifer G. Straumins, John G. Boss, Karen A. Twitchell and Todd Borgmann (collectively, the “Appointed Directors”) to the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.